摘要
目的:应用HPLC建立注射用美罗培南韦博巴坦的含量测定方法。方法:采用Shimadzu InertSustain C_(18)(150 mm×4.6 mm,5μm)色谱柱,以乙腈-0.02 mol·L^(-1)磷酸二氢钠溶液(用磷酸调pH至2.8)(10∶90)为流动相,流速1.0 mL·min^(-1),检测波长210 nm,进样体积10μL。结果:在本方法中,美罗培南和韦博巴坦的线性良好,线性范围分别为21.40~214.0μg·mL^(-1)和19.83~198.3μg·mL^(-1);美罗培南和韦博巴坦精密度良好,RSD分别为0.17%和0.23%。24 h内,美罗培南和韦博巴坦在4℃条件下稳定性良好,RSD分别为0.31%和0.16%。美罗培南和韦博巴坦的平均加样回收率良好,分别为101.0%(n=9)和98.4%(n=9)(RSD均<2.0%)。运用该方法测得该药品中美罗培南及韦博巴坦的含量分别为405.8、399.1 mg·g^(-1)。结论:该测定方法准确、简单、快速,可用于测定注射用美罗培南韦博巴坦的含量。
Objective:To develop a method for the determination of meropenem and vaborbactam for injection by HPLC.Methods:The chromatography was performed on Shimadzu InertSustain C_(18)(150 mm×4.6 mm,5μm)column with acetonitrile-0.02 mol·L^(-1)sodium dihydrogen phosphate solution(adjust pH to 2.8 with phosphoric acid)(10∶90)as a mobile phase,the flow rate was 1.0 mL·min^(-1),the detection wavelength was 210 nm,and the sample volume was 10μL.A method for the determination of meropenem and vaborbactam for injection was established under the chromatographic conditions.Results:In this method,the linearities of meropenem and vaborbactam were good,and the linearity ranges were 21.40-214.0μg·mL^(-1)and 19.83-198.3μg·mL^(-1).Meropenem and vaborbactam had good precision with RSD of 0.31%and 0.16%,respectively.Within 24 h,meropenem and vaborbactam had good stabilities at 4℃,RSDs were 0.31%and 0.16%,respectively.The average recoveries of meropenem and vaborbactam were 101.0%(n=9)and 98.4%(n=9)(RSD<2.0%).The contents of meropenem and vaborbactam were 405.8 mg·g^(-1)and 399.1 mg·g^(-1),respectively.Conclusion:The method is accurate,simple and rapid,and can be used for the determination of meropenem and vaborbactam for injection.
作者
王晶
徐硕
王月
郭思瑞
徐文峰
金鹏飞
WANG Jing;XU Shuo;WANG Yue;GUO Si-rui;XU Wen-feng;JIN Peng-fei(Department of Pharmacy,Beijing Hospital,National Center of Gerontology,Institute of Geriatric Medicine,Chinese Academy of Medical Sciences,Beijing Key Laboratory of Assessment of Clinical Drugs Risk and Individual Application,Beijing 100730,China)
出处
《药物分析杂志》
CAS
CSCD
北大核心
2024年第10期1679-1684,共6页
Chinese Journal of Pharmaceutical Analysis
基金
中关村精准医学基金会医健公益行药学科研专项(ZGC-YXKY-43)。